课题基金 / 基金详情

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF VALPROATE TO ATTENUAT

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF VALPROATE TO ATTENUAT
丙戊酸减毒的随机、双盲、安慰剂对照试验
批准号:
7717984
负责人:
JEFFREY L. CUMMINGS
金额:
$0.11万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-12-01 至 2008-11-30

项目摘要

项目成果

JEFFREY L. CUMMINGS的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. SPECIFIC AIMS: To demonstrate in a randomized, placebo-controlled clinical trial whether chronic valproate therapy delays the emergence of agitation and/or psychosis in outpatients with probable Alzheimer's disease (AD) who have not experienced agitation and psychosis in their illness.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Alzheimer's Disease and Related Dementias Innovation Incubator (InnovaTor)
  • 批准号:
    10738969
  • 项目类别:
  • 资助金额:
    $25.35万
  • 财政年份:
    2023
  • 负责人:
    JEFFREY L. CUMMINGS
  • 依托单位:
Alzheimer's Clinical Trial InnOvatioN (ACTION) Initiative
  • 批准号:
    10180707
  • 项目类别:
  • 资助金额:
    $59.76万
  • 财政年份:
    2021
  • 负责人:
    JEFFREY L. CUMMINGS
  • 依托单位:
Alzheimer's Clinical Trial InnOvatioN (ACTION) Initiative
  • 批准号:
    10604326
  • 项目类别:
  • 资助金额:
    $58.57万
  • 财政年份:
    2021
  • 负责人:
    JEFFREY L. CUMMINGS
  • 依托单位:
Alzheimer's Clinical Trial InnOvatioN (ACTION) Initiative
  • 批准号:
    10388232
  • 项目类别:
  • 资助金额:
    $59.16万
  • 财政年份:
    2021
  • 负责人:
    JEFFREY L. CUMMINGS
  • 依托单位: